Literature DB >> 17609905

Research and development of new Chinese materia medica for treatment of refractory hematopathy by establishment and application of multiple technique platforms.

Rui-lan Gao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17609905     DOI： 10.1007/s11655-007-0095-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


× No keyword cloud information.
  6 in total

1.  [Effect of ginsenosides on proliferation and differentiation of human CD34+ hematopoietic stem/progenitor cells].

Authors:  J Jin; H Tao; R Gao
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2000-09

2.  [The intracellular signaling pathway initiated by ginsenosides in hematopoietic cells].

Authors:  R Gao; C Wu; B H Chong
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  1999-06

3.  [Up-regulation of transcription factors GATA-1 and GATA-2 induced by Panax notoginosides in hematopoietic cells].

Authors:  Rui-lan Gao; Wei-hong Xu; Xiao-jie Lin; Xiao-hong Chen; Chao-qun Wu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2004-05

4.  [Effect of Panax notoginsenosides on the proliferation of hematopoietic progenitor cells in mice with immune-mediated aplastic anemia].

Authors:  Yun Gai; Rui-lan Gao; Yang-ping Niu
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2003-09

5.  [Up-regulation of transcription factors NF-E2, c-jun and c-fos of AP-1 family induced by Panax Notoginosides in hematopoietic cells].

Authors:  Rui-Lan Gao; Wei-Hong Xu; Xiao-Hong Chen; Xu-Dai Qian; Chao-Qun Wu
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2004-02

6.  Treatment of 37 patients with refractory idiopathic thrombocytopenic purpura by shengxueling.

Authors:  Ke-ding Shao; Yu-hong Zhou; Yi-ping Shen; Bao-dong Ye; Rui-lan Gao; Yu Zhang
Journal:  Chin J Integr Med       Date:  2007-03       Impact factor: 2.626
  6 in total
  7 in total

1.  Clinical study of pai-neng-da capsule in the treatment of chronic aplastic anemia.

Authors:  Yue-min Kuang; Yan Zhu; Rui-lan Gao; Jing Hu; Zhi-yong Jiang; Li Huang; Ya-jun Tong; Xin-guo Luo; Xin-fang Gao; Zhi-yin Zheng
Journal:  Chin J Integr Med       Date:  2015-08-14       Impact factor: 1.978

2.  Research and development of the effective components of panaxdiol saponin as new Chinese patent medicine for treating hemocytopenia.

Authors:  Rui-lan Gao; Beng Hock Chong
Journal:  Chin J Integr Med       Date:  2012-12-13       Impact factor: 1.978

3.  Panaxdiol Saponins Component Promotes Hematopoiesis and Modulates T Lymphocyte Dysregulation in Aplastic Anemia Model Mice.

Authors:  Zhi-Yin Zheng; Xiao-Ling Yu; Tie-Ying Dai; Li-Ming Yin; Yan-Na Zhao; Min Xu; Hai-Feng Zhuang; Beng Hock Chong; Rui-Lan Gao
Journal:  Chin J Integr Med       Date:  2019-12-04       Impact factor: 1.978

4.  Ginseng-Derived Panaxadiol Saponins Promote Hematopoiesis Recovery in Cyclophosphamide-Induced Myelosuppressive Mice: Potential Novel Treatment of Chemotherapy-Induced Cytopenias.

Authors:  Xin Sun; Yan-Na Zhao; Song Qian; Rui-Lan Gao; Li-Ming Yin; Li-Pei Wang; Beng-Hock Chong; Su-Zhan Zhang
Journal:  Chin J Integr Med       Date:  2017-04-22       Impact factor: 1.978

5.  Panax notoginseng saponins induced up-regulation, phosphorylation and binding activity of MEK, ERK, AKT, PI-3K protein kinases and GATA transcription factors in hematopoietic cells.

Authors:  Xin Sun; Rui-Lan Gao; Xiao-Jie Lin; Wei-Hong Xu; Xiao-Hong Chen
Journal:  Chin J Integr Med       Date:  2013-01-31       Impact factor: 1.978

6.  Panaxdiol saponins component promotes hematopoiesis by regulating GATA transcription factors of intracellular signaling pathway in mouse bone marrow.

Authors:  Tie-Ying Dai; Jin-Jian Lan; Rui-Lan Gao; Yan-Na Zhao; Xiao-Ling Yu; Simon-Xun Liang; Wen-Bin Liu; Xin Sun
Journal:  Ann Transl Med       Date:  2022-01

7.  GPX3 methylation is associated with hematologic improvement in low-risk myelodysplastic syndrome patients treated with Pai-Neng-Da.

Authors:  Shujun Yang; Tong Gao; Zhonghua Zheng; Binbin Lai; Lixia Sheng; Zhijuan Xu; Xiao Yan; Jiaping Wang; Shiwei Duan; Guifang Ouyang
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.